MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 … Read more
MeiraGTx Holdings PLC (MGTX) - Total Liabilities
Latest total liabilities as of September 2025: $230.03 Million USD
Based on the latest financial reports, MeiraGTx Holdings PLC (MGTX) has total liabilities worth $230.03 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MeiraGTx Holdings PLC - Total Liabilities Trend (2016–2024)
This chart illustrates how MeiraGTx Holdings PLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MeiraGTx Holdings PLC Competitors by Total Liabilities
The table below lists competitors of MeiraGTx Holdings PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Northwest Biotherapeutics Inc
OTCQB:NWBO
|
USA | $139.26 Million |
|
Hidili Industry International Development Limited
PINK:HIIDQ
|
USA | $10.78 Billion |
|
Cerence Inc
NASDAQ:CRNC
|
USA | $451.60 Million |
|
Hypothekarbank Lenzburg AG
SW:HBLN
|
Switzerland | CHF7.55 Billion |
|
Shenzhen Centralcon Investment Holding Co Ltd
SHE:000042
|
China | CN¥31.48 Billion |
|
Xiamen Xindeco Ltd
SHE:000701
|
China | CN¥14.46 Billion |
|
STEF S.A
LSE:0NY3
|
UK | €2.84 Billion |
|
Shoei Co Ltd
PINK:SHOFF
|
USA | $4.52 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down MeiraGTx Holdings PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MeiraGTx Holdings PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MeiraGTx Holdings PLC (2016–2024)
The table below shows the annual total liabilities of MeiraGTx Holdings PLC from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $201.92 Million | +7.08% |
| 2023-12-31 | $188.57 Million | -5.95% |
| 2022-12-31 | $200.50 Million | +48.78% |
| 2021-12-31 | $134.76 Million | +7.69% |
| 2020-12-31 | $125.14 Million | -5.97% |
| 2019-12-31 | $133.09 Million | +740.44% |
| 2018-12-31 | $15.84 Million | -78.37% |
| 2017-12-31 | $73.22 Million | +84.48% |
| 2016-12-31 | $39.69 Million | -- |